Atlas Venture Advisors, Inc. - Q4 2021 holdings

$720 Million is the total value of Atlas Venture Advisors, Inc.'s 7 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 12.5% .

 Value Shares↓ Weighting
IAS BuyINTEGRAL AD SCIENCE HLDNG CO$504,672,000
+7.7%
22,722,771
+0.0%
70.13%
+26.3%
DKNG  DRAFTKINGS INC$180,083,000
-43.0%
6,555,6080.0%25.02%
-33.1%
ROKU  ROKU INC$13,169,000
-27.2%
57,7070.0%1.83%
-14.5%
SNAP  SNAP INCcl a$11,549,000
-36.3%
245,5590.0%1.60%
-25.3%
VRDN  VIRIDIAN THERAPEUTICS INC$4,142,000
+20.2%
209,5050.0%0.58%
+41.2%
LRMR  LARIMAR THERAPEUTICS INC$3,153,000
-6.4%
292,1840.0%0.44%
+9.8%
FSTX  F-STAR THERAPEUTICS INC$2,886,000
-31.4%
574,9960.0%0.40%
-19.5%
BCYC ExitBICYCLE THERAPEUTICS PLCsponsored ads$0-307,696
-100.0%
-1.52%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-01-27
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SNAP INC20Q3 20236.1%
ROKU INC16Q3 202311.7%
LARIMAR THERAPEUTICS INC14Q3 20231.4%
TRANSLATE BIO INC11Q2 202152.9%
INTEGRAL AD SCIENCE HLDNG CO10Q3 202371.2%
BICYCLE THERAPEUTICS PLC10Q3 202125.2%
VIRIDIAN THERAPEUTICS INC10Q1 20232.1%
F-STAR THERAPEUTICS INC9Q4 20221.3%
DRAFTKINGS INC8Q1 202282.5%
MIRAGEN THERAPEUTICS INC8Q3 20205.0%

View Atlas Venture Advisors, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-02
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04

View Atlas Venture Advisors, Inc.'s complete filings history.

Compare quarters

Export Atlas Venture Advisors, Inc.'s holdings